CHEMISTRY

Google's 'Smart Reply' Will Answer Emails For You

Google's parent company Alphabet is presenting a new email program that determines on your behalf what emails get a short response or prepares a few replies. Dubbed as the 'Smart Reply', answering email can now be a tap away.

Banning Dangerous Research: Hindering Vaccination Development

Is the suspension of the Vaccine development really for the better The gain of function (GOF) studies has been around for years. It's more popular for the term mutation, which scientists have been applying to a lot of things such as viruses, to create more potent and high class deadly virus and eventually find the cure or the perfect vaccine that could fight against the current deadly viral diseases such as MERS, SARS and Influenza.

The Danger of Powdered Caffeine

Warning letters were sent to five distributors of pure powdered caffeine because of the detrimental side effects it posed to its consumers.

Fatty Deposits Could Trigger Alzheimer's Disease

A new discovery could be the medical breakthrough for the dreaded type of Dementia. A fact that had been overlooked for so many years has just been recognized as one of the catalysts for the Alzheimer's disease.

Urine Test Detects Pancreatic Cancer At An Early Age

Pancreatic cancer belongs to the deadliest cancer of the world and has the highest listed date rate. Early detection of pancreatic cancer can lead to high survival rate and this can be done with a simple urine test.

Ecstasy for the Terminally Ill? Will This Party Drug Prove Effective Against Anxiety?

Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).

Recommended Stories